AI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
Enhancing Health Literacy Through Artificial Intelligence-Powered Chatbot: A Randomized Controlled Trial on Addressing Human Papillomavirus Vaccination Misinformation Among Caregivers in Japan
1 other identifier
interventional
804
1 country
1
Brief Summary
The goal of this study is to learn if an innovative digital artificial intelligence (AI)-based communication tool works to enhance health literacy among Japanese caregivers regarding Human Papillomavirus (HPV) vaccination. Participants will:
- Answer a pre-intervention survey, get information regarding HPV vaccination from an AI-based chatbot or leaflet, and answer a post-intervention survey.
- Continue interacting with the chatbot or leaflet for two weeks.
- Answer a follow-up survey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Nov 2024
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 25, 2024
CompletedStudy Start
First participant enrolled
November 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2024
CompletedJuly 30, 2026
April 1, 2026
27 days
November 20, 2024
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
health literacy
Health literacy related to HPV vaccination will be measured by changes in caregivers' scores on questions concerning facts about HPV vaccines and associated health information. The score consists of 7 factual questions, with total scores ranging from 0 to 7 based on the number of correct responses. Higher scores indicate greater literacy. This metric will be evaluated by determining the proportion of respondents who correctly answer these questions, reflecting their understanding and knowledge.
2 weeks
Secondary Outcomes (1)
decision-making
2 weeks
Study Arms (2)
AI-based chatbot
EXPERIMENTALA chatbot that was developed using information related to HPV vaccines from authoritative sources such as the Japanese Ministry of Health, Labour, and Welfare, World Health Organization, Centers for Disease Control and Prevention, and other reputable public health organizations and validated survey questions from published research.
Leaflet
ACTIVE COMPARATORA leaflet which is a publicly accessible HPV vaccination document prepared by the Ministry of Health, Labour, and Welfare.
Interventions
A publicly accessible HPV vaccination leaflet prepared by the Ministry of Health, Labour, and Welfare.
Eligibility Criteria
You may qualify if:
- A nationally representative sample of female caregivers with daughters aged 12-18 who have not received any HPV vaccine.
- Those who have access to a smartphone or computer with internet connectivity to interact with experiment materials (chatbot or online leaflet).
- Those who provide informed consent and agree to participate in the study.
You may not qualify if:
- Those who need help reading through the participant information sheet, providing consent online, accessing experiment materials (chatbot or online leaflet), or answering surveys will be excluded. This may include people who do not have access to an online environment or people with severe cognitive impairments who cannot interact with the experiment materials. Also, those who have participated or are participating in similar studies regarding vaccination or experiments that utilize chatbots will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- London School of Hygiene and Tropical Medicinecollaborator
- Nagasaki Universitycollaborator
Study Sites (1)
London School of Hygiene and Tropical Medicine
London, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Leesa Lin, PhD
London School of Hygiene and Tropical Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 25, 2024
Study Start
November 30, 2024
Primary Completion
December 27, 2024
Study Completion
December 27, 2024
Last Updated
July 30, 2026
Record last verified: 2026-04